Antiviral drugs have traditionally been developed by directly targeting essential viral
components. However, this strategy often fails due to the rapid generation of drug-resistant …

Influenza viruses, including four major types (A, B, C, and D), can cause mild-to-severe and
lethal diseases in humans and animals. Influenza viruses evolve rapidly through antigenic …

ABSTRACT SARS-CoV-2, the etiological agent of COVID-19, is characterized by a delay in
type I interferon (IFN-I)-mediated antiviral defenses alongside robust cytokine production …

ABSTRACT A novel human coronavirus (HCoV-EMC) was recently identified in the Middle
East as the causative agent of a severe acute respiratory syndrome (SARS) resembling the …

Influenza viruses cause seasonal epidemics and pandemic outbreaks associated with
significant morbidity and mortality, and a huge cost. Since resistance to the existing anti …

Influenza viruses are major human pathogens responsible for respiratory diseases affecting
millions of people worldwide and characterized by high morbidity and significant mortality …

Recent genome-wide association and transcriptome-wide association studies have
identified an association between the PALMD locus, encoding palmdelphin, a protein …

The recent pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection (COVID-19) is a viral respiratory disease that has been spread all over the globe …

Influenza viruses, the main cause of respiratory tract diseases, cause high morbidity and
mortality in humans. Excessive inflammation in the lungs is proposed to be a hallmark for the …

Influenza A viruses (IAVs) are a major cause of respiratory illness and are responsible for
yearly epidemics associated with more than 500,000 annual deaths globally. Novel IAVs …